Your browser doesn't support javascript.
loading
A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome.
Christie, Jason D; Vaslef, Steven; Chang, Philip K; May, Addison K; Gunn, Scott R; Yang, Shuying; Hardes, Kelly; Kahl, Lesley; Powley, William M; Lipson, David A; Bayliffe, Andrew I; Lazaar, Aili L.
Afiliación
  • Christie JD; 1Pulmonary and Critical Care Medicine, University of Pennsylvania School of Medicine, Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA. 2Department of Surgery, Duke University Medical Center, Durham, NC. 3Department of Surgery, University of Kentucky, Lexington, KY. 4Division of Trauma and Surgical Critical Care, Vanderbilt University Medical Center, Nashville, TN. 5Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA. 6GlaxoSmithKline
Crit Care Med ; 43(9): 1859-69, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26102252

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piridonas / Pirimidinas / Síndrome de Dificultad Respiratoria / Heridas y Lesiones / Mediadores de Inflamación / Proteínas Quinasas p38 Activadas por Mitógenos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Crit Care Med Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piridonas / Pirimidinas / Síndrome de Dificultad Respiratoria / Heridas y Lesiones / Mediadores de Inflamación / Proteínas Quinasas p38 Activadas por Mitógenos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Crit Care Med Año: 2015 Tipo del documento: Article